BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $111,677,559.41 |
| Submission deadline | Deadline not published |
| Published | Mar 12, 2025 |
| Buyer | Office of Assistant Secretary for Preparedness and Response |
| Country | United States · IL |
| CPV code | NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING) · PSC 6505 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $111,677,559.41
- Submission deadline
- Deadline not published
- Published
- Mar 12, 2025
- Country
- United States
- CPV code
- NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING) · PSC 6505
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| FRESENIUS KABI, LLC | US-UEI: C2TRNWNQKMD6 | United States | $111,677,559.41 | Mar 12, 2025 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER
Awarding Agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response.
NAICS 325412: PHARMACEUTICAL PREPARATION MANUFACTURING.
PSC 6505: DRUGS AND BIOLOGICALS.
Period of Performance: 2025-03-14 to 2030-03-13.